Skip to the main content.

Cell and Gene Therapy Series. Part 7 - Manufacturing Paradigms part II

Cell and Gene Blog Series: Part 7 - Future ATMP Manufacturing Paradigms

We wrap up this Cell and Gene series with a final blog - 7. Follow the link to continue learning about the future of ATMPs' manufacturing paradigm.

CAR-T cell therapy for cancer: The patient's in the process

CAR-T cell therapy for cancer: The patient's in the process

Around 1,000 people are diagnosed with cancer every day in the UK. Fortunately, outcomes continue to improve, with around half of those diagnosed...

Read More
Engineering Challenges in Designing Pharmaceutical Isolators

Engineering Challenges in Designing Pharmaceutical Isolators

In this latest blog, James Lau, one of 3P’s Project Engineers, tells us all about barrier systems across a range of areas. Specifically taking a...

Read More
Formulation Freedom in Clinical Development: Why Fill2Weight Matters

Formulation Freedom in Clinical Development: Why Fill2Weight Matters

In early-stage pharmaceutical development, poor powder flow is rarely the root issue, it’s simply a symptom. The real challenge for formulation...

Read More